Elevations in the Mitochondrial Matrix Protein Cyclophilin D Correlate With Reduced Parvalbumin Expression in the Prefrontal Cortex of Patients With Schizophrenia
Article in Schizophrenia Bulletin (February 2024)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study
Article in Neurobiology of Disease (August 2023)
The mitochondrial matrix protein cyclophilin D contributes to deficits in parvalbumin interneurons in schizophrenia
Preprint in bioRxiv (May 2023)